• A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures

    Apr 1, 2018, 00:00

  • Emerging Good Practices for Transforming Value Assessment- Patients’ Voices, Patients’ Values

    Apr 1, 2018, 00:00

  • What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

    Apr 1, 2018, 00:00

  • Improving Value for Patients with Eczema

    Apr 1, 2018, 00:00

  • The Value Challenge- Examining the Transformative Strategies to Measure or Evaluate the Value of Health Care Interventions

    Apr 1, 2018, 00:00

  • Comparing 15D Valuation Studies in Norway and Finland—Challenges When Combining Information from Several Valuation Tasks

    Apr 1, 2018, 00:00

  • The ICER Value Framework- Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance

    Mar 1, 2018, 00:00

  • Associations of Smoking, Physical Inactivity, Heavy Drinking, and Obesity with Quality-Adjusted Life Expectancy among US Adults with Depression

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease

    Mar 1, 2018, 00:00

  • Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients

    Mar 1, 2018, 00:00

  • Table of Contents

    Mar 1, 2018, 00:00

  • What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than £10,000/QALY?

    Mar 1, 2018, 00:00

  • Paying for Cures- Perspectives on Solutions to the “Affordability Issue”

    Mar 1, 2018, 00:00

  • Sensitivity of Claims-Based Algorithms to Ascertain Smoking Status More Than Doubled with Meaningful Use

    Mar 1, 2018, 00:00

  • Resource Use and Cost of Alzheimer’s Disease in France- 18-Month Results from the GERAS Observational Study

    Mar 1, 2018, 00:00

  • Affordability of Health Care- A Global Crisis

    Mar 1, 2018, 00:00

  • Resolving the “Cost-Effective but Unaffordable” Paradox- Estimating the Health Opportunity Costs of Nonmarginal Budget Impacts

    Mar 1, 2018, 00:00

  • Editorial Board

    Mar 1, 2018, 00:00

  • Affordability Challenges to Value-Based Pricing- Mass Diseases, Orphan Diseases, and Cures

    Mar 1, 2018, 00:00

  • Copyright/Subscription

    Mar 1, 2018, 00:00

  • The Importance of Model Structure in the Cost-Effectiveness Analysis of Primary Care Interventions for the Management of Hypertension

    Mar 1, 2018, 00:00

  • Affordability of New Technologies- The Next Frontier

    Mar 1, 2018, 00:00

  • Real-World Evidence- Useful in the Real World of US Payer Decision Making? How? When? And What Studies?

    Mar 1, 2018, 00:00

  • Estimating the Learning Curve of a Novel Medical Device- Bipolar Sealer Use in Unilateral Total Knee Arthroplasties

    Mar 1, 2018, 00:00

  • Investigating the Heterogeneity in Women’s Preferences for Breast Screening- Does the Communication of Risk Matter?

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- A Missed Opportunity for ISPOR and Patients

    Feb 1, 2018, 00:00

  • The Impact of Decision Makers’ Constraints on the Outcome of Value of Information Analysis

    Feb 1, 2018, 00:00

  • Defining Elements of Value in Health Care—A Health Economics Approach- An ISPOR Special Task Force Report [3]

    Feb 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis

    Feb 1, 2018, 00:00

  • A Comparison of Different Approaches for Costing Medication Use in an Economic Evaluation

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Frameworks- Serving the Needs of Decision Making

    Feb 1, 2018, 00:00

  • Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

    Feb 1, 2018, 00:00

  • Editorial Board

    Feb 1, 2018, 00:00

  • Review of Recent US Value Frameworks—A Health Economics Approach- An ISPOR Special Task Force Report [6]

    Feb 1, 2018, 00:00

  • Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease

    Feb 1, 2018, 00:00

  • Choice Defines Value- A Predictive Modeling Competition in Health Preference Research

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Introduction- An ISPOR Special Task Force Report [1]

    Feb 1, 2018, 00:00

  • Copyright/Subscription

    Feb 1, 2018, 00:00

  • Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach- An ISPOR Special Task Force Report [4]

    Feb 1, 2018, 00:00

  • Table of Contents

    Feb 1, 2018, 00:00

  • Corrections to ’Systematic Literature Review and Indirect Treatment Comparison of the Efficacy of Semaglutide versus Empagliflozin as Add-On to Basal Insulin (PDB4)’

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- Seeking a Role for Health Economics

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

    Feb 1, 2018, 00:00

  • An Overview of Value, Perspective, and Decision Context—A Health Economics Approach- An ISPOR Special Task Force Report [2]

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- An Industry Perspective

    Feb 1, 2018, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Systematic Review and Network Meta-Analysis

    Feb 1, 2018, 00:00

  • Corrections to ‘Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0’ [JVAL 20/8 (2017) 1009–1022]

    Feb 1, 2018, 00:00

  • Approaches to Aggregation and Decision Making—A Health Economics Approach- An ISPOR Special Task Force Report [5]

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- The Use of Cost-Effectiveness Research in Decision Making among US Insurers

    Feb 1, 2018, 00:00

  • Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer

    Jan 1, 2018, 00:00

  • Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States

    Jan 1, 2018, 00:00

  • Accounting for Uncertainty in Decision Analytic Models Using Rank Preserving Structural Failure Time Modeling- Application to Parametric Survival Models

    Jan 1, 2018, 00:00

  • Table of Contents

    Jan 1, 2018, 00:00

  • Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care

    Jan 1, 2018, 00:00

  • Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices- An Application for Eliciting Patient Preferences for Diabetes Treatments

    Jan 1, 2018, 00:00

  • Editorial Board

    Jan 1, 2018, 00:00

  • Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis- An Indirect Comparison Using Individual Patient Data from Randomized Trials

    Jan 1, 2018, 00:00

  • Instructions for Authors

    Jan 1, 2018, 00:00

  • Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes

    Jan 1, 2018, 00:00

  • Women’s Benefits and Harms Trade-Offs in Breast Cancer Screening- Results from a Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically- Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies

    Jan 1, 2018, 00:00

  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available- A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes

    Jan 1, 2018, 00:00

  • An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds

    Jan 1, 2018, 00:00

  • The Burden of Peristomal Skin Complications on an Ostomy Population as Assessed by Health Utility and the Physical Component Summary of the SF-36v2

    Jan 1, 2018, 00:00

  • EQ-5D- Moving from Three Levels to Five

    Jan 1, 2018, 00:00

  • EQ-5D-5L versus EQ-5D-3L- The Impact on Cost Effectiveness in the United Kingdom

    Jan 1, 2018, 00:00

  • Trading Bankruptcy for Health- A Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer

    Dec 1, 2017, 00:00

  • Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions- An Illustration for Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2017, 00:00

  • Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease

    Dec 1, 2017, 00:00

  • An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions- The EQ-5D Case Study

    Dec 1, 2017, 00:00

  • Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands- A Country Adaptation Analysis Under the Former and Current Du ...

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit

    Dec 1, 2017, 00:00

  • Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure- A Network Meta-Analysis

    Dec 1, 2017, 00:00

  • Table of Contents

    Dec 1, 2017, 00:00

  • Letter to the Editor- Emerging Guidelines for Patient Engagement in Research

    Dec 1, 2017, 00:00

  • Scientific Evidence in Health Technology Assessment Reports- An In-Depth Analysis of European Assessments on High-Risk Medical Devices

    Dec 1, 2017, 00:00

  • Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise

    Dec 1, 2017, 00:00

  • Copyright/Subscription

    Dec 1, 2017, 00:00

  • Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer- The OPTIMA Prelim Trial

    Dec 1, 2017, 00:00

  • A (Latent) Class of Their Own- Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises

    Dec 1, 2017, 00:00

  • ISPOR Code of Ethics 2017 (4th Edition)

    Dec 1, 2017, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Cost-Utility Analysis

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Comparing Methods for Estimating Direct Costs of Adverse Drug Events

    Dec 1, 2017, 00:00

  • Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors

    Dec 1, 2017, 00:00

  • Author Response- Patient Engagement

    Dec 1, 2017, 00:00

  • Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial- An Update with Empirical Trial–Based Cost Data

    Dec 1, 2017, 00:00

  • The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies- Findings from the INITIATOR Study

    Dec 1, 2017, 00:00

  • Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation- A Multicriteria Decision Analysis

    Dec 1, 2017, 00:00

  • Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation

    Dec 1, 2017, 00:00

  • Next Edition of the ISPOR Code of Ethics- Is It Setting Us up for the Era of Digitized Health Care?

    Dec 1, 2017, 00:00

  • Development and Validation of the AFImpact- An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life

    Dec 1, 2017, 00:00

  • Reviewer Acknowledgement 20/10

    Dec 1, 2017, 00:00

  • Health Care System

    Dec 1, 2017, 00:00

  • The Role of Noncomparative Evidence in Health Technology Assessment Decisions

    Dec 1, 2017, 00:00

  • Value and Impact of Incorporating Uncertainty into Opinion Based Research- Study on American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) for Cystic Fibrosis (CF)

    Oct 1, 2017, 00:00

  • Pricing Pressures And Market Access Outcomes Of Advanced Therapy Medicinal Products (Atmps) In The Eu5

    Oct 1, 2017, 00:00

  • When And Where To Use Furigana? The Application Of Phonetic Notation In Japanese Translations Of Clinical Outcomes Assessments (COAS) For Children

    Oct 1, 2017, 00:00

  • The Impact Of Human Papillomavirus Vaccine In Taiwan- A Transmission Dynamic Modelling Approach

    Oct 1, 2017, 00:00

  • Patient Insights In Copd Medication Adherence From Pharmacy Data

    Oct 1, 2017, 00:00

  • The Association Between Buprenorphine/Naloxone and All-Cause Mortality in the United Kingdom (UK)- An Interim Report

    Oct 1, 2017, 00:00

  • Economic Evaluation Of A Brief Counselling For Smoking Cessation In Dentistry – A Case Study Comparing Two Health Economic Models

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Afatinib Versus Gefitinib in Egfr-Mutated Population with Advanced Non-Small-Cell Lung Cancer in France

    Oct 1, 2017, 00:00

  • Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life after Major Lower Extremity Amputation Due to Musculoskeletal Tumors

    Oct 1, 2017, 00:00

  • Evolution of The Time-To-Market of Hospital Products In Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Edoxaban In Patients With Non-Valvular Atrial Fibrillation In Hong Kong

    Oct 1, 2017, 00:00

  • Modelling Patient Pathways Of Low-Dose Computed Tomography Screening For Lung Cancer In Hungary

    Oct 1, 2017, 00:00

  • Safety of A Specific First Line Antiretroviral Regimen- A Review

    Oct 1, 2017, 00:00

  • The Analysis Of New Drug Reimbursement Decision Making In South Korea After The Introduction Of Positive Listing System

    Oct 1, 2017, 00:00

  • Dispute Issues About The Healing And Health Promotion Of Children

    Oct 1, 2017, 00:00

  • Impact Of Non-Randomised Drop-Out On Treatment Switching Adjustment In The Relapsing-Remitting Multiple Sclerosis Clarity Trial And The Clarity Extension Study

    Oct 1, 2017, 00:00

  • The Real-World Impact Of Mild To Moderate Hypoglycemic Events In Portugal – Results From The Hipos-Pharma Study

    Oct 1, 2017, 00:00

  • Systematic Review On Economic Impact Of Air Pollution On Health

    Oct 1, 2017, 00:00

  • Economic Burden of Autism and Autism-Related Spectrum Disorders (Asd) In EU5 Countries

    Oct 1, 2017, 00:00

  • The Utilisation Of Biosimilar Infliximab By English Acute Trusts

    Oct 1, 2017, 00:00

  • Comparison of the Assessments and Recommendations Issued by Brazil’s Conitec and Canada’s Cadth for Select Oncology Drugs

    Oct 1, 2017, 00:00

  • Determining The Value of Selexipag For The Treatment of Pulmonary Arterial Hypertension (PAH) In Spain By Multi-Criteria Decision Analysis (MCDA)

    Oct 1, 2017, 00:00

  • Intensity Modulated Radiation Therapy In Malignant Pleural Mesothelioma; A Piolt For Treatment Outcomes And Cost-Effective Expectations

    Oct 1, 2017, 00:00

  • Análisis Comparativo De Costos Entre Trastuzumab Para Administración Subcutánea En Comparación Con La Formulación Para Administración Intravenosa Desde La Perspectiva De La Seguridad Social Costarricense

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis- A Canadian Perspective

    Oct 1, 2017, 00:00

  • Intermediate Evaluation of Vivoptim- The Mgen (French Insurer) Prevention Program for Cardiovascular Risks

    Oct 1, 2017, 00:00

  • Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis- A Cross-Country Review of Access Conditions

    Oct 1, 2017, 00:00

  • Real-World Data Analysis of Cancer Treatment Cost Drivers By Type and Place of Service

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Thresholds- Review Of Cases Around The World

    Oct 1, 2017, 00:00

  • Costs and Benefits of Implementing Non-Invasive Prenatal Testing For Trisomy 21 (T21) Based on Cell Free DNA (CFDNA) Sequencing In Maternal Plasma In France

    Oct 1, 2017, 00:00

  • Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke

    Oct 1, 2017, 00:00

  • Cost and Effectiveness of the use of Sorafenib in Differentiated Thyroid Cancer

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apixaban In Prevention of Stroke And Systemic Embolism In The Czech Republic

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Modeling Evaluation Comparing Originator Follitropin Alfa To A Biosimilar For The Treatment of Infertility In Germany, Italy And Spain

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia B Patients Using Standard And Extended Half-Life Recombinant Factor IX Products

    Oct 1, 2017, 00:00

  • Characterization And Approximation Of The Direct Costs Of Axial And Peripheral Spondyloarthritis In A Clinical Management Center In Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Real Life Cost of Treatment and Follow-Up in Glioblastoma Multiforme (GBM) Patients Treated at the Antwerp University Hospital (UZA), Belgium

    Oct 1, 2017, 00:00

  • Descalonamento Da Terapia Antimicrobiana- Uma Estratégia De Racionalização E Custo-Minimização Em Cenário Privado De Saúde No Ceará

    Oct 1, 2017, 00:00

  • Impact of Metabolic Surgery on Cost and Long-Term Health Outcome- A Cost-Effectiveness Approach

    Oct 1, 2017, 00:00

  • Economic Impact Of Floseal In Cardiac Surgery From The Perspective Of The Mexican Institute Of Social Security (IMSS)

    Oct 1, 2017, 00:00

  • Real World Evidence in Glaucomatous Diseases- Emr Data is Indispensible For Understanding Patient Journeys and Optimizing Care

    Oct 1, 2017, 00:00

  • Advanced Monte-Carlo Sampling Schemes for Value of Information Estimation

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00

  • Decision Analytic Modelling Methods For The Assessing The Effectiveness Of Treatment Sequences For Clinical And Economic Decision Making- A Methodological Review

    Oct 1, 2017, 00:00

  • Effects of Adherence to Pharmacological Secondary Prevention After Myocardial Infarction on Healthcare Expenditures

    Oct 1, 2017, 00:00

  • Capturing Patient Perspectives In The Evaluation Of Medical Devices- The Case Of Central Venous Access Devices In Chemotherapy

    Oct 1, 2017, 00:00

  • Secondary Care Resource Utilization And Cost Of Care Among Finnish Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Pharmacoepidemiological Survey Of Under- Five Antidiarrhea Drugs Utilization In A Tertiary Teaching Hospital In Enugu Metropolis Southeast Nigeria

    Oct 1, 2017, 00:00

  • Conceptual Modeling Framework for Global Functioning of Adhd Patients

    Oct 1, 2017, 00:00

  • Efficacy-Based Budget Impact Analysis of Secukinumab Vs Adalimumab in the Treatment of Ankylosing Spondylitis in Finland

    Oct 1, 2017, 00:00

  • Impact Of Seasonal Infections On Overcrowding In A Paediatric Department Of A French Hospital In Marseille- A Retrospective Analysis

    Oct 1, 2017, 00:00

  • Estimating The Drug Treatment Cost of Breast Cancer

    Oct 1, 2017, 00:00

  • Association Between Monthly Joint Replacement Volume and Patient Outcomes

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden- Analysis Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Xelox Versus Folfox No Tratamento Do Câncer Colorretal- Revisão De Estudos Farmacoeconômicos

    Oct 1, 2017, 00:00

  • Time To Market Access For Oncology Medicines In Gree Has It Changed During The Crisis?

    Oct 1, 2017, 00:00

  • Hospital Costs Associated With Dedicated Vascular Endoprosthesis Versus Prosthetic Bypass In Popliteal Artery Aneurysm Treatment In France

    Oct 1, 2017, 00:00

  • Economic Evaluation And Budget Impact Analysis Of Prothrombin Complex Concentrate (Beriplex®) For Treatment And Prophylaxis Of Bleeding In Patients Treated With Oral Anticoagulants Under Perspective Of Health Public Institutions In Mexico

    Oct 1, 2017, 00:00

  • Payers, Politics and Pandemonium- An Insight Into The Future Uk Pricing and Market Access Environment

    Oct 1, 2017, 00:00

  • Longitudinal Study into the Dispensing Patterns of Benzodiazepines and Z-Drugs in a South African Private Healthcare Setting

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared With Standard Acei Therapies For Heart Failure Patients With Reduced Ejection Fraction In Taiwan

    Oct 1, 2017, 00:00

  • Budget Impact Model of Cobimetinib in Combination with Vemurafenib For Previously Untreated Braf V600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

    Oct 1, 2017, 00:00

  • Publication Timing and Data Utilisation in Cost-Effectiveness Analyses in Non-Small Cell Lung Cancer – A Literature Analysis on Publication Timing

    Oct 1, 2017, 00:00

  • Social And Financial Impact Of Dravet Syndrome

    Oct 1, 2017, 00:00

  • Cost Associated with Ballon-Expandable Valve vs Self-Expandable Valves in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • An Innovative Solution to Achieve Cost-effectiveness and A Positive Nice Appraisal? – The Cabazitaxel Case Study

    Oct 1, 2017, 00:00

  • Community Pharmacists’ Interest In And Attitude To Pharmacy Practice Research In Ethiopia- A Cross-Sectional Study

    Oct 1, 2017, 00:00

  • Maximum Difference Scaling To Enhance Insight In Qualitative Payer Research

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Treatment with Ultibro Breezhaler® Versus Seretide Diskus® 50/500 Μg for Moderate to Very Severe COPD Patients

    Oct 1, 2017, 00:00

  • Processes And Requirements For Health Economic Assessment Of Antibiotics For Hta Purposes- Time For A Paradigm Shift?

    Oct 1, 2017, 00:00

  • A Retrospective Study On The Antiretroviral Drug Dispensing And Adherence Of The Hungarian HIV Infected Population

    Oct 1, 2017, 00:00

  • Retrospective Analysis of Patients Treated with Computer-Assisted External Ring Fixators- A Descriptive Analysis of Patient Demographics, Healthcare Untilization, And Costs In The U.S

    Oct 1, 2017, 00:00

  • Navigating The Road To Reimbursement And Optimizing Uptake For Oncology Agents In The EU5- Payer And Prescriber Perspectives On The Power Of Pivotal Trial Design

    Oct 1, 2017, 00:00

  • A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Urban Breast Cancer Screening Programme In China

    Oct 1, 2017, 00:00

  • Implementability Evaluation Of Antibiotics For Abdominal Trauma Guideline Using The Guideline Implementability Appraisal (GLIA) Tool

    Oct 1, 2017, 00:00

  • IQWIG´S GENERAL METHODS 5.0 - WHAT´S NEW?

    Oct 1, 2017, 00:00

  • Time To Clinically Meaningful Worsening In Hepatocellular Carcinoma Patients Treated With Lenvatinib or Sorafenib

    Oct 1, 2017, 00:00

  • AVALIAÇÃO ECONÔMICA DE TECNOLOGIAS NA ÁREA DE NUTRIÇÃO- APLICAÇÕES E LIMITAÇÕES PARA O CONTEXTO BRASILEIRO

    Oct 1, 2017, 00:00

  • Phase I/II Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • 10 Years Of Reimbursement Decisions In The Netherlands- An Overview

    Oct 1, 2017, 00:00

  • Effectiveness and Persistence of The First Tumor Necrosis Factor Inhibitor In Portuguese Psoriatic Arthritis Patients

    Oct 1, 2017, 00:00

  • Are PR Approval Of Orphan Drugs (ODS) In Spain?

    Oct 1, 2017, 00:00

  • Relation of QLQ-C30 and QLQ-CR29 Health Related Quality of Life Scales and Biochemical Indicators of Nutritional Status

    Oct 1, 2017, 00:00

  • An Evidence-Based Approach to Predict Long-Term Patient Outcomes and Key Value Drivers

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure With Reduced Ejection Fraction In Korea

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Dexmedetomidine Versus Propofol Or Midazolam Sedation In Mechanical Ventilated Icu Patients In Spain

    Oct 1, 2017, 00:00

  • Microbiological, Chemical Analysis and Comparison of Public Bath Waters in Baranya County Between 2010-2016

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Biosimilar Rituximab (CT-P10) For The Treatment Of Diffuse Large B-Cell And Follicular Lymphoma In The 28 EU Member States

    Oct 1, 2017, 00:00

  • Early Scientific Advice At Cadth – Options and Recommendations For Future Development

    Oct 1, 2017, 00:00

  • Clinical Outcome Assessments For Patients With Hemophilia

    Oct 1, 2017, 00:00

  • Gene-Therapy, The Way Forward In Europe – The Payer Perspective

    Oct 1, 2017, 00:00

  • Remote Therapy Management Of Patients On Automated Peritoneal Dialysis Demonstrates Cost Savings In Germany And Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Apremilast for The Treatment of Moderate To Severe Psoriasis In Greece

    Oct 1, 2017, 00:00

  • Examining Global Occurrence Of Complications Related To Peripheral Iv Catheters Using A Focused Literature Review

    Oct 1, 2017, 00:00

  • Secukinumab vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from a Brazilian Perspective

    Oct 1, 2017, 00:00

  • The Presentation Of Patients With Epistaxis Shows A Marked Seasonal Variation In Germany

    Oct 1, 2017, 00:00

  • Defining Criteria Weights By AHP In Health Technology Assessment

    Oct 1, 2017, 00:00

  • Healthcare Costs of Ipilimumab in Patients with Advanced Cutaneous Melanoma in Dutch Clinical Practice

    Oct 1, 2017, 00:00

  • Economic Burden of Gastric Cancer in Turkey

    Oct 1, 2017, 00:00

  • Evaluating Endpoints and Changing Trends In Advanced Stages of Cancer Related Clinical Trials

    Oct 1, 2017, 00:00

  • Quality of Life And Utility Decrement Associated With Clostridium Difficile Infection In French Acute Care Facilities

    Oct 1, 2017, 00:00

  • Visual Outcome of Cataract Surgery At Gondar University Hospital Tertiary Eye Care and Training Center, North West Ethiopia

    Oct 1, 2017, 00:00

  • Analytical Hierarchical Process for Evaluation of First Line Treatment of Metastatic HER2 Overexpressed Breast Cancer from Brazilian Health System Perspective

    Oct 1, 2017, 00:00

  • Identification Of Important Criteria For Drug Reimbursement Decision-Making And Their Relative Importance

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Sacubitril/Valsartan Introduction For Heart Failure Treatment From The French Hospital Perspective

    Oct 1, 2017, 00:00

  • Disease-Modifying Therapy Is Associated With Lower Medical Costs In Patients With Multiple Sclerosis With or Without Corticosteroid Treatment- A Us Retrospective Claims-Based Study

    Oct 1, 2017, 00:00

  • A Longitudinal Investigation Of The Relationships Between Patient-Reported Symptoms And Survival Among Patients with HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib In The Phase 2 Monarch 1 Trial

    Oct 1, 2017, 00:00

  • DATABASE ANALYSIS OF A SUPPORT PROGRAM FOR PEDIATRIC PATIENTS USING SOMATROPIN DUE TO GROWTH HORMONE DEFICIENCY (GHD)

    Oct 1, 2017, 00:00

  • Patients’ Priorities for Oral Anticoagulation Therapy in Non-Valvular Atrial Fibrillation

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of A Multi-Gene Panel In The Context Of Reducing Adverse Drug Reactions

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Breech Version By Moxibustion Associated With Acupuncture For Women At 33 Weeks Gestation- A Modeling Approach By The Brazilian Public Health Care System Perspective

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total HIP Replacement- Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 120,000 Patie ...

    Oct 1, 2017, 00:00

  • Epidemiology of Multiple Sclerosis- Literature Review for Prevalence and Trend Over Time in 5 European Countries and Canada

    Oct 1, 2017, 00:00

  • Treatment Patterns for Adult Patients with Newly Diagnosed Focal Epilepsy in Germany

    Oct 1, 2017, 00:00

  • Physiotherapeautic Methods Aimed To Improve The Cardiorespiratory State Before And After Operation In Patients With Lung Cancer

    Oct 1, 2017, 00:00

  • Second-Line Therapy In Patients with Locally Advanced or Metastatic Urothelial Cancer- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Epidemiology of Physician-Diagnosed Neuropathic Pain in Brazil

    Oct 1, 2017, 00:00

  • Preliminary Results of Restarting Oral Anticoagulant Treatment In Patients with Non-Valvular Atrial Fibrillation Following Intracranial Hemorrhage- A Population-Based Cohort Study

    Oct 1, 2017, 00:00

  • Factors Associated with Medication Adherence in Korean Postmenopausal Osteoporosis(PMO)- Results from PMO Outcomes Research(OR)

    Oct 1, 2017, 00:00

  • A Cost-Utility Analysis Of Raasi Enabling-Patiromer In Patients With Hyperkalemia

    Oct 1, 2017, 00:00

  • Creating Order In Chaos - The Impact Of Brexit On The Regulatory Environment In Europe And The United Kingdom

    Oct 1, 2017, 00:00

  • Review Of Models Submitted To Nice Medical Technologies Evaluation Programme To Inform A Cost Consequence Template For Use In Medical Technologies Guidance Submissions

    Oct 1, 2017, 00:00

  • Análisis Del Costo De La Atención Del Parto En Medellín

    Oct 1, 2017, 00:00

  • From Evaluation To Optimization- Using A Meta-Model To Maximize The Benefits Of Colorectal Screening Accounting For Capacity Constraints

    Oct 1, 2017, 00:00

  • Maximizing The Value of Wearable By The Remote Collection And Analysis Of Raw 100hz Data

    Oct 1, 2017, 00:00

  • Impacto Económico Directo Derivado De La Atención De Pacientes Traumatizados En UN Hospital De México

    Oct 1, 2017, 00:00

  • A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods

    Oct 1, 2017, 00:00

  • Cost of Treatment for Chronic Hepatitis C Infection at a National Tertiary-Care Referral Centre in an Asian Middle-Income Country

    Oct 1, 2017, 00:00

  • A Discrete Event Simulation Model For Renal Cell Carcinoma For Use In A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Willingness-To-Pay For Life-Saving Treatments In Thailand- A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Assessment Of Herpes Zoster Vaccination In Germany

    Oct 1, 2017, 00:00

  • The Future of Precision Medicine- What Does it Mean for Nice?

    Oct 1, 2017, 00:00

  • Comparing the Efficacy, Safety, and Efficiency Outcomes Between Lensx Femtosecond Laser-Assisted Cataract Surgery and Phacoemulsification Cataract Surgery- A Meta-Analysis

    Oct 1, 2017, 00:00

  • Cost Savings of Perioperative Anemia Treatment with Ferric Carboxymaltose In Colorectal Cancer Surgery Patients

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Renal Replacement Therapy for Critically ILL Acute Kidney Injury Patients Under the Perspective of the Brazilian Private Healthcare System

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Dolutegravir In HIV-1 Treatment-Naive Patients In Russia

    Oct 1, 2017, 00:00

  • Opioid Utilization And Cost Among Elderly And Non-Elderly Medicare Beneficiaries In The United States- A State-Level Comparison

    Oct 1, 2017, 00:00

  • Secukinumab As A More Efficient Alternative For The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis Versus Adalimumab And Golimumab From A Colombian Perspective

    Oct 1, 2017, 00:00

  • Examination of The Effectiveness of Core Training Between Junior Women Basketball Players To Prevent Sports Injuries

    Oct 1, 2017, 00:00

  • Explaining Waiting Times for Scheduled Surgery Using A High-Dimensional Fixed Effects Model

    Oct 1, 2017, 00:00

  • Analysis Of Hospital Episode Statistics To Identify Hopsital Resource Use Due To Skin Cancer In Ireland

    Oct 1, 2017, 00:00

  • Type of Ancestral Native Plants Used as Intestinal Antiparasitic in Indigenous Communities- The Evanes Project

    Oct 1, 2017, 00:00

  • HTA Analysis of Intraocular Lenses After Cataract Surgery- Hydrophobic Vs. Hydrophilic Lenses - Health Technology Assessment In Slovak Healthcare Environment

    Oct 1, 2017, 00:00

  • Gasto Y Cobertura De Inmunización En Niños Menores De Un Año De Edad En Ecuador

    Oct 1, 2017, 00:00

  • Prevalence And Perception Of Antibiotics Use In Balochistan

    Oct 1, 2017, 00:00

  • Prescription Writing Errors Detection by Pharmacist in A Pediatric Ward

    Oct 1, 2017, 00:00

  • The Role of Patient-Reported Outcomes and Patient Engagement In Health Technology Assessments and Reimbursement Decision Making In 10 Countries

    Oct 1, 2017, 00:00

  • Detección Temprana Del Cáncer De Pulmón

    Oct 1, 2017, 00:00

  • Budget Impact of Atezolizumab for The Treatment of 2nd Line Non-Small Cell Lung Cancer (NSCLC) After Failure with Platinum Containing Chemotherapy in Greece

    Oct 1, 2017, 00:00

  • Survival Effect, Demand Effect And Policy Effect As Drivers For Pricing Of Innovatives Anticancer Drugs

    Oct 1, 2017, 00:00

  • Analysis of the G-BA Decision-Making Criteria on the Benefit Assessment of Diabetes Treatments- Is Cost an Influencing Criterion?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective- Evidence From The Switch 12 Trials

    Oct 1, 2017, 00:00

  • Statistical Methods for Critical Care Outcomes

    Oct 1, 2017, 00:00

  • Budgetary Impact Analysis of the Nutritional Home Care Service

    Oct 1, 2017, 00:00

  • Societal Costs of Er+/Her2- Advanced or Metastatic Breast Cancer in Post-Menopausal Women in The United Kingdom

    Oct 1, 2017, 00:00

  • Diferencias Geográficas En La Salud Auto-Percibida Comunal De Chile

    Oct 1, 2017, 00:00

  • GROWTH FACTORS FOR THE MANAGEMENT OF DIABETIC FOOT ULCERS- MIXED TREATMENT COMPARISONS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2017, 00:00

  • Systematic Review Of Economic Evaluation Studies For Dengue Vaccine- How Valid Are The Results?

    Oct 1, 2017, 00:00

  • Do we Know Enough Yet? A Cumulative Cost-Effectiveness Analysis of Mechanical Thrombectomy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Fidaxomicin Versus Vancomycin And Metronidazole In Patients With Clostridium Difficile Infection In Spain

    Oct 1, 2017, 00:00

  • Constituição De Protocolos Clínicos E Diretrizes Terapêuticas Para Doenças Negligenciadas No Brasil

    Oct 1, 2017, 00:00

  • Trends In Emerging Non-Hta Drug Value Assessment Frameworks

    Oct 1, 2017, 00:00

  • Patient Care Pathway for Post-Stroke Spasticity and Bont Management in French Hospitals Through the Prism of PMSI Data

    Oct 1, 2017, 00:00

  • Burden Of Diabetes Mellitus In Patients With Acromegaly Treated With Second-Line Pharmacotherapy In Spain

    Oct 1, 2017, 00:00

  • Fluoroquinolone-Related Adverse Events Resulting In Health Care Use And Costs- A Systematic Review

    Oct 1, 2017, 00:00

  • Reimbursed Drugs with Alternative Payment Model in Turkey

    Oct 1, 2017, 00:00

  • Análise De Impacto Orçamentário Do Crizotinibe No Tratamento Do Câncer De Pulmão Não Pequenas Células Avançado Alk-Positivo Sob a Perspectiva Do Sistema Privado De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis In Health Economic Models; How Many Simulations Should We Run?

    Oct 1, 2017, 00:00

  • The Situation and Importance of Peritoneal Dialysis In Renal Failure- Economic Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Three European Countries Using 28-Month Overall Survival from Checkmate 067

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Brazil

    Oct 1, 2017, 00:00

  • Dispensing Patterns of Anti-Migraine Agents with the Focus On Seasonal Variations In Prescribing

    Oct 1, 2017, 00:00

  • Maintaining The Belt And Road – The Impact of 'Brexit' on UK Market Access

    Oct 1, 2017, 00:00

  • Nice’s New Budget Impact Threshold – What Proportion Of Drugs Is This Likely To Affect?

    Oct 1, 2017, 00:00

  • Effect of Pharmacist Care on Medication Adherence and Cardiovascular Outcomes Among Patients Post-Acute Coronary Syndrome- A Systematic Review

    Oct 1, 2017, 00:00

  • The Use Of Intra-Class Correlation Coefficients To Assess Test-Retest Reliabilities In Psychometric Evaluations Of Patient Reported Outcome Measures

    Oct 1, 2017, 00:00

  • A Model-Based Meta-Analysis For The Effect of Metformin On Hba1c Levels In Patients With Type-2 Diabetes Mellitus

    Oct 1, 2017, 00:00

  • Testosterone Replacement therapy As An Anti-Ageing Treatment for Men- A Literature Review and Economic Evaluation

    Oct 1, 2017, 00:00

  • Incorporating Dependence Between Model Parameters In Uncertainty Analyses

    Oct 1, 2017, 00:00

  • Impacto Del Índice De Masa Corporal En La Salud Autopercibida- Resultados De La Encuesta Nacional De Salud De Chile 2016-2017

    Oct 1, 2017, 00:00

  • A Multicenter, Observational Study To Evaluate Comorbidities In Patients Above 50 Years Of Age – Aging Positive- Characterization Of The Healthcare Resource Use

    Oct 1, 2017, 00:00

  • Economic Evaluation of Multi-Drug Resistant Tuberculosis In Ghana- Patient Level Direct Cost Analysis 2013 - 2016

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures on Health Utilities in PPMS

    Oct 1, 2017, 00:00

  • Interrogating Social Media Sources to Gain Insight on Opioid-Induced Constipation Symptoms as Reported By Patients

    Oct 1, 2017, 00:00

  • Cataract Prevalence Estimation and Financial Requirements for Surgery Unmet Needs in Mexico- A Secondary Sources Analysis

    Oct 1, 2017, 00:00

  • The Economic Burden of Coeliac Disease in North America and Europe- A Systematic Review

    Oct 1, 2017, 00:00

  • Primary Treatment Patterns Among Glaucoma Patients In Korea From 2002 To 2013 Using The National Health Insurance System Claims Data

    Oct 1, 2017, 00:00

  • Determinantes Dos Custos Dos Processos Judiciais De Medicamentos Em Um Município Da Região Centro-Oeste Do Brasil

    Oct 1, 2017, 00:00

  • A Saúde Do Trabalhador Em Questão- Análise Do Absenteísmo E O Perfil Dos Atestados Médicos Em Um Hospital De Grande Porte No Ceará

    Oct 1, 2017, 00:00

  • Health Service Implications Of The Implementation Of An Early Discharge Strategy For Patients Admitted In Infectious Diseases Departments In Southern Europe

    Oct 1, 2017, 00:00

  • Value of Needleless Safety Devices For IV Voriconazole In Prevention of Needlestick Injury (NSI)

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis Of Increasing Peritoneal Dialysis (PD) In Adults Experiencing Unplanned Start Dialisys (Urgent Start) In Brazil

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Universal Neonatal Hearing Screening With Otoacoustic Emissions And/Or Automated Auditory Brainstem Response, For The Detection Of Bilateral Congenital Hearing Loss And Early Treatment, In Newborns Without Risk Factors ...

    Oct 1, 2017, 00:00

  • Evaluation of Barriers To Effective Insulin Therapy Among Type 2 Diabetes Mellitus Patients

    Oct 1, 2017, 00:00

  • Assessing The Implications Of The Nice Budget Impact Test- How Many Oncology Regimens Will Be Affected And What Will Be The Impact On Patient Outcomes?

    Oct 1, 2017, 00:00

  • The Value Of Real-World Evidence To Support Value-Based Decision-Making- Examples For Vedolizumab In Inflammatory Bowel Disease

    Oct 1, 2017, 00:00

  • ADC, NOT AS EASY AS 123 - The Unprecedented Example Of Trastuzumab-Emtansine In The Nice Appraisal Process

    Oct 1, 2017, 00:00

  • Detection And Management Of Diabetes In England- Results From The Health Survey For England

    Oct 1, 2017, 00:00

  • Primary Data Collection Versus use of Retrospective Claims Data- Methodology Lessons Learned from A Linked Database Study in Chronic Obstructive Pulmonary Disease (COPD)

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole for The Treatment of Post-Menopausal Women with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced or Metasta ...

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Strategies for Cervical Cancer Prevention and Control in Indonesia

    Oct 1, 2017, 00:00

  • Determining The Brazilian Population Health Status- Estimate Of Health Production Function

    Oct 1, 2017, 00:00

  • Treatment Patterns Of Second-Line (2L) Metastatic Urothelial Cancer (MUC) In Spain

    Oct 1, 2017, 00:00

  • Which Are The Most Common Quality of Life Health States In Latin America? A Pareto Analysis of A Collaborative Project Using Euroqol Eq-5d In Argentina, Brazil, Chile and Uruguay

    Oct 1, 2017, 00:00

  • A Literature Review of Health Economic Assessments, Health Care Resource Utilization (HCRU), and Health Related Quality-of-Life (HRQOL) in Patients with Gastric Cancer (GC)

    Oct 1, 2017, 00:00

  • Symptoms and Impacts in Metastatic Castration-Resistant Prostate Cancer- Qualitative Study Findings

    Oct 1, 2017, 00:00

  • Non-Quantifiable Benefit Within The German Amnog System- Factors Contributing To Time Limits Set For Benefit Resolutions And Potential Implications On Price Discounts

    Oct 1, 2017, 00:00

  • Establishing A Medication Error Reporting And Monitoring Programme In A Developing Country’s Tertiary Care Teaching Hospital

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of 10% Intravenous Immunoglobulin Compared With Plasma Exchange In Treatment Of Children With Guillain–Barré Syndrome In Russia

    Oct 1, 2017, 00:00

  • Estimating The Excess Costs of Community-Acquired Pneumonia In Elderly People In Japan

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of A Novel Breath-Triggered Aerosol Inhaler Which Has Been Designed To Reduce The Critical Handling Error of Insufficient Inspiratory Effort

    Oct 1, 2017, 00:00

  • Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • No Evidence For An Association Between Renal Function And Bleeding Events In Patients On Coumarin Therapy- A Population-Based Study

    Oct 1, 2017, 00:00

  • Neutrophil-To-Lymphocyte Ratio (NLR) As A Predictor For Recurrencein Patients With Stage Iii Melanoma

    Oct 1, 2017, 00:00

  • ASSOCIATION Between Second-Line Therapy (2LT) Regimen Type, Duration of Therapy (DOT), and Time To Next Treatment (TTNT) In A United States (US) Relapsed/Refractory Multiple Myeloma (RRMM) Cohort- An Electronic Medical Records (EMR)-Based S ...

    Oct 1, 2017, 00:00

  • Coverage Evidence Development in the Course of the Drug Reevaluation in Korea

    Oct 1, 2017, 00:00

  • Exploring Concurrent Validity of The CLN2 Clinical Rating Scale- Comparison To Pedsql Using Mixed Effects Modelling And Data From A Phase 1/2 Single-Arm Trial

    Oct 1, 2017, 00:00

  • Forecasting Pharmaceutical Expenditure In Europe- Adjusting For The Impact Of Rebates And Discounts

    Oct 1, 2017, 00:00

  • Discrete Event Simulation Modelling of Long Term Cost-Effectiveness of Internet-Based Blended Cognitive Behavioural Therapy for Major Depressive Disorder- Extrapolation of the E-Compared Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation Of Phid-CV Versus PCV-13 In Slovakia

    Oct 1, 2017, 00:00

  • Subcutaneous Drugs In Oncology- Make A Difference In The Treatment? Systematic Review From Different Analytical Perspectives

    Oct 1, 2017, 00:00

  • Quality of life improvement in a heart failure clinical program vs. Conventional management in a specialized clinic in colombia

    Oct 1, 2017, 00:00

  • Are LABA/LAMA/ICS FDCS A Triple Threat for COPD Competitors in the Cost-Constrained EU5?

    Oct 1, 2017, 00:00

  • A Markov Microsimulation Model For The Economic Evaluation Of Partially Implantable Active Middle Ear Implants In Sensorineural Hearing Loss

    Oct 1, 2017, 00:00

  • Quality-Adjusted Life Years (QALYS) for Inotuzumab Ozogamicin Versus Investigators Choice (IC) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia (R/R B-ALL)

    Oct 1, 2017, 00:00

  • Comparison of Budesonide Inhalers For Treatment of Asthma In Adults And Adolescents In Russian Federation- Cost – Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Approaches To Modelling The Cost-Effectiveness Of Interventions For Heart Failure- A Systematic Review

    Oct 1, 2017, 00:00

  • Spirometry Comparison Between Smokers and Non-Smokers Students in University of Balochistan,Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Brazilian Public Healthcare System Actions to Care For Children With Microcephaly

    Oct 1, 2017, 00:00

  • A Via Administrativa E Judicial Como Forma De Acesso Aos Medicamentos No Sistema Público De Saúde Brasileiro

    Oct 1, 2017, 00:00

  • The Comparison Among Different Countries’ EQ-5D-5L Value Sets Applied In Chinese General Population

    Oct 1, 2017, 00:00

  • Association Between Socioeconomic Deprivation And Cancer Incidence And Outcomes Among English CCGS

    Oct 1, 2017, 00:00

  • Evaluating The Cost-Utility Of Immunosuppressive Regimens In Liver Transplant Recipients In Canada

    Oct 1, 2017, 00:00

  • Target Organ Damage And The Long Term Effect of Nonadherence To Clinical Practice Guidelines In Patients With Hypertension- A Retrospective Cohort Study

    Oct 1, 2017, 00:00

  • Prevalence of Overweight and Obesity Among Health Personnel in an Urban Ghana- A Descriptive Cross-Sectional Study, 2017

    Oct 1, 2017, 00:00

  • Newly Diagnosed Multiple Myeloma (NDMM) Patient Profiles; Findings From An Observational Chart Review In France, Germany, Italy, Spain And The United Kingdom

    Oct 1, 2017, 00:00

  • Advanced Therapy Medicinal Products – Transformational Patient Benefits But Destined for Commercial Failure?

    Oct 1, 2017, 00:00

  • Drug Commercialization Before The Pricing And Reimbursement In Italy- The Non Negotiated C Class (C-NN)

    Oct 1, 2017, 00:00

  • The Cost and Outcomes of Breast Cancer Screening for Women 40-49 Years Old in Russia

    Oct 1, 2017, 00:00

  • Antecipação Ao Rol De Procedimentos Da Agência Nacional De Saúde Suplementar- Impacto Orçamentário Da Incorporação De Um Novo Inibidor De Tirosina-Quinase

    Oct 1, 2017, 00:00

  • Burn Care Outside Burn Centers In Germany; Results From An Analysis of Hospital Quality Reports

    Oct 1, 2017, 00:00

  • Custos Diretos No Tratamento De Câncer De Mama- Olhar Estratégico De Uma Operadora De Planos De Saúde Do Brasil

    Oct 1, 2017, 00:00

  • Lipid-Lowering Treatment Patterns and Possible Associated Statin Intolerance in Patients with Clinical Atherosclerotic Cardiovascular Disease (ASCVD) or Diabetes Mellitus (DM) in Taiwan

    Oct 1, 2017, 00:00

  • Cost Saving Analysis of Encephalogram Bispectral Index Monitoring (Bis) During Ten Different Types of Elective Surgeries in Colombia

    Oct 1, 2017, 00:00

  • Association Between Tumour Lesion Size and Health-Related Quality of Life Outcomes in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

    Oct 1, 2017, 00:00

  • Budget Impact Analysis For Switching From Manual To Pre-Filled Syringes For Catheter Maintenance

    Oct 1, 2017, 00:00

  • The Value Of Beds With Continuous Lateral Rotation Therapy To Prevent Ventilator-Associated Pneumonia And Pressure Injuries- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Low Density Lipoprotein Cholesterol (LDL-C) Target Goal Achievement Rate According to Physicians’ Compliance to Established Clinical Guidelines from National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) and American Colleg ...

    Oct 1, 2017, 00:00

  • Metodology To Assess Pricing And Reimburesment (PR) Potential In Central And European (CEE) Countries

    Oct 1, 2017, 00:00

  • Preliminary Results Of Benefits Study - Brazilian Economic Evaluation Of Sflt-1/Plgf Test For Preeclampsia Prediction And Diagnosis- Private Perspective

    Oct 1, 2017, 00:00

  • Comparative Analysis of Lists of Antifungal Preparations for Onychomycosis Treatment In British and Ukrainian National Formularies

    Oct 1, 2017, 00:00

  • Quality of Life of Pregnant Women in Russian Federation

    Oct 1, 2017, 00:00

  • Availability of Health Economic Model Inputs In Japan- A Targeted Literature Review

    Oct 1, 2017, 00:00

  • Pro-Ctcae Impact on Payer Evaluations of Oncologic Therapies- A Qualitative Research Study

    Oct 1, 2017, 00:00

  • Electronic Patient-Reported Outcomes- Are There Gaps Between Guidance And Issues Encountered In Practice?

    Oct 1, 2017, 00:00

  • Inconclusive Eviden Can Pharmacoeconomics Tilt The Balance?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Coblation Technology VS. Mechanical Debridement With A Shaver In The Treatment Of Knee Cartilage Lesions- A Spanish Payer Perspective

    Oct 1, 2017, 00:00

  • MÉTODOS DE ANÁLISE MULTICRITÉRIO EMPREGADOS NA SELEÇÃO DE MEDICAMENTOS

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Prasugrel For Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention In Spain

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of The Sufentanil Sublingual Tablet System Vs Iv Pca Morphine For The Treatment of Acute Moderate To Severe Post-Operative Pain In Ireland

    Oct 1, 2017, 00:00

  • Treatment Persistence In Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies

    Oct 1, 2017, 00:00

  • Is it Possible to Accurately Identify Rare Diseases Using National Hospital Discharge Databases?

    Oct 1, 2017, 00:00

  • Patient Counts Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • An Empirical Analysis of The Role of Learning by Doing in Dynamic Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Identifying Patients With Lupus Nephritis in the United Kingdom (Uk) Clinical Practice Research Datalink (Cprd)

    Oct 1, 2017, 00:00

  • Results Of Individual Participant Data Meta-Analysis VS Aggregate Data Meta-Analysis Of RCTS Of Exercise Rehabilitation In Chronic Heart Failure

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Invasive Fungal Infections Therapies In Febrile Neutropenic Patients With Hematological Malignancies In The Turkish Context

    Oct 1, 2017, 00:00

  • When The Outcome of An Appraisal Is Not Ni A Review Of Nice Appeals

    Oct 1, 2017, 00:00

  • Biosimilar Uptake In The Uk- An Evolving Story?

    Oct 1, 2017, 00:00

  • Multiple Chronic Conditions in Older People and their Effects on Health Care Utilization- A Network Analysis Approach Using Share Data

    Oct 1, 2017, 00:00

  • A Cost Consequences Analysis of The Human Body Posturizer In Italy

    Oct 1, 2017, 00:00

  • A Review Of Economic Evaluations Considering Screening Interventions For The Risk Assessment Of Venous Thromboembolism In Women Considering Combined Oral Contraceptives

    Oct 1, 2017, 00:00

  • A Multi-Centre Retrospective Study To Describe The Impact on Healthcare Resource Use And Real World Effectiveness of Golimumab In Ankylosing Spondylitis (AS) In UK Clinical Practice

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Daclizumab Beta In The Treatment of Relapsing Remitting Multiple Sclerosis In Italy

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Direct Aspiration First Pass Technique (ADAPT) For Thrombectomy Revascularization of Large Vessel Occlusion In Acute Ischemic Stroke (French Health Ministry Prme 16-0020)

    Oct 1, 2017, 00:00

  • Cost-Utility Of Prasugrel Compared To Clopidogrel For Preventing Cardiovascular Events In Diabetic Patients With Acute Coronary Syndrome In Brazil

    Oct 1, 2017, 00:00

  • Cognitive Debriefing Of The Dmd-Specific Measures Of Physical Functioning – Caregiver Questionnaire

    Oct 1, 2017, 00:00

  • The Effect of Changing Utility Elicitation Methods in Cardiovascular Disease- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Análise Da Qualidade Da Evidência Científica Entre Xelox E Folfox No Tratamento Do Câncer Colorretal

    Oct 1, 2017, 00:00

  • Diagnosis Of Patients With Duchenne Muscular Dystrophy (DMD)- Results From A Global Survey Of Healthcare Providers From Nine Countries

    Oct 1, 2017, 00:00

  • Uncertainty In Selecting Survival Models For Cost Effectiveness Analyses

    Oct 1, 2017, 00:00

  • Comparative Efficacy And Safety Of Olaparib 300 Mg Tablets Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients With Platinum-Sensitive Relapsed Germline BRCA-Mutated Ovarian Cancer (PSROC) ...

    Oct 1, 2017, 00:00

  • Pre-Hospital Pain Relief Treatment In Patients With Musculoskeletal Injuries Experiencing Moderate To Severe Pain In Medical Emergencies

    Oct 1, 2017, 00:00

  • Characterising the Relative Impact of Established Cardiovascular Disease and Chronic Kidney Disease on Quality of Life in Diabetes Patients

    Oct 1, 2017, 00:00

  • Intravenous Iron Treatments For Iron Deficiency Anemia In Inflammatory Bowel Disease- A Budget Impact Analysis Of Iron Isomaltoside 1000 In The UK

    Oct 1, 2017, 00:00

  • Number Needed to Treat (NNT) and Cost of Preventing an Event (COPE) Comparison Between the Association of Cobimetinib and Vemurafenib Among Other Treatment Options for Metastatic Melanoma With BRAF V600 Mutation

    Oct 1, 2017, 00:00

  • Calculating The Indirect Costs Of Adult Pneumococcal Disease And The Rate Of Return To The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) In Older Adults, With An Application To Denmark

    Oct 1, 2017, 00:00

  • How To Address French Health Authority (HAS/CEESP) Specific Requirements In Modelling Relapsing-Remitting Multiple Sclerosis In Health-Economic Evaluation? Modelling Treatment Sequences

    Oct 1, 2017, 00:00

  • Can Bayesian Methodology Predict Long-Term Effectiveness Rather Than Efficacy? An Application with Overall Survival in Two Oncology Indications

    Oct 1, 2017, 00:00

  • Uso De Medicamentos Inapropriados Em Idosos Institucionalizados No Município De São Paulo, Brasil

    Oct 1, 2017, 00:00

  • Acceptance of Population-Adjusted Indirect Treatment Comparison Methods In Nice Assessments

    Oct 1, 2017, 00:00

  • Use of Abiraterone And Enzalutamide In Metastatic Castration-Resistant Prostate Cancer In Routine Clinical Practice

    Oct 1, 2017, 00:00

  • The Impact of Missed Treatment Opportunities on Outcomes In Hospitalised Heart Failure Patients- Modelling Analysis Based on The National Heart Failure Audit

    Oct 1, 2017, 00:00

  • Pharmacy Workload And Workforce Requirement At Ministry Of Health Hospitals During Ten Years Mass Gathering Hajj (2006-2015) In Makah Region, Saudi Arabia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Midostaurin (MIDO) with Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)

    Oct 1, 2017, 00:00

  • Prospective Assessment of The Accuracy, Reliability and Cost-Effectiveness of Staging Non-Small Cell Lung Cancer (NSCLC) Only with The Combination of Pet/Ct and Brain MRI

    Oct 1, 2017, 00:00

  • Pricing Pantoprazole In Gree A Tale Of Distortion

    Oct 1, 2017, 00:00

  • New Modelling Approaches In Ophthalmology- Partitioned Vision Distrbution Model In Symptomatic Vitreomacular Adhesion (VMA)/Vitreomacular Traction (VMT) With Or Without Full-Thickness Macular Hole (FTMH)

    Oct 1, 2017, 00:00

  • Assessing the Burden of Chronic Heart Failure on Caregivers of Patients in Colombia

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72
  • 73 (current)
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »